Literature DB >> 17628371

Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.

Marie-Laure Pujol1, Vincent Cirimele, Pierre Julien Tritsch, Marion Villain, Pascal Kintz.   

Abstract

This work presents the validation of a new immunological assay, the One-Step enzyme-linked immunosorbent assay (ELISA) tests from International Diagnostic Systems Corp. for the screening of drugs of abuse (cannabis, amphetamines, opiates, and cocaine) in human hair, with subsequent GC-MS confirmation. After decontamination and segmentation into small pieces, 50 mg of hair sample were incubated in 1 ml of methanol during 16 h at 40 degrees C. A 100 microL aliquot was collected and evaporated to dryness in presence of 100 microL of methanol/hydrochloric acid (99:1, v/v) to avoid amphetamines loss. The dried extract was dissolved in 100 microL of the "sample and standard diluent" solution included in the kit. This solution was submitted to analysis according to the recommended instructions of the manufacturer. During the validation phase, GC-MS confirmations were conducted according to our fully validated and published methods for opiates, cocaine, cannabis, and amphetamines determinations in hair. In a last development step, these procedures were slightly modified to directly confirm ELISA results by GC-MS using the methanolic extract. Ninety-three specimens were simultaneously screened by the ELISA tests (103 for tetrahydrocannabinol (THC)) and confirmed by GC-MS. Twenty were found positive for cannabis (THC: 0.10-6.50 ng/mg), 21 for cocaine (0.50-55.20 ng/mg), 24 for opiates (6-acetylmorphine (6-AM): 0.20-11.60 ng/mg, MOR: 0.20-8.90 ng/mg, codeine (COD): 0.20-5.90 ng/mg), and 13 for amphetamines (AP: 0.20 and 0.27 ng/mg, methamphetamine (MAP): 0.30 and 1.10 ng/mg, methylenedioxymethamphetamine (MDMA): 0.22-17.80 ng/mg). No false negative results were observed according to the Society of Hair Testing's (SoHT) cutoffs (0.5 ng/mg for cocaine, 0.2 ng/mg for opiates and amphetamines, and 0.1 ng/mg for THC). The One-Step ELISA kits appear suitable due to their sensitivity and specificity for drug of abuse screening in hair. This technology should find interest in workplace drug testing or driving license regranting, especially when many samples have to be tested with a high rate of negative samples, as ELISA is an easy and high-throughput method.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628371     DOI: 10.1016/j.forsciint.2007.02.032

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  6 in total

1.  Spot tests: past and present.

Authors:  María Teresa Doménech-Carbó; Antonio Doménech-Carbó
Journal:  ChemTexts       Date:  2021-12-27

2.  Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use.

Authors:  Jan Gryczynski; Robert P Schwartz; Shannon Gwin Mitchell; Kevin E O'Grady; Steven J Ondersma
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

3.  Rapid detection and quantitation of drugs-of-abuse by wooden-tip electrospray ionization mass spectrometry.

Authors:  Tsz-Tsun Ng; Pui-Kin So; Bin Hu; Zhong-Ping Yao
Journal:  J Food Drug Anal       Date:  2018-10-01       Impact factor: 6.157

4.  A Novel Tetrahydrocannabinol Electrochemical Nano Immunosensor Based on Horseradish Peroxidase and Double-Layer Gold Nanoparticles.

Authors:  Dingqiang Lu; Fuping Lu; Guangchang Pang
Journal:  Molecules       Date:  2016-10-17       Impact factor: 4.411

Review 5.  A review of bioanalytical techniques for evaluation of cannabis (Marijuana, weed, Hashish) in human hair.

Authors:  Iltaf Shah; Bayan Al-Dabbagh; Alaa Eldin Salem; Saber A A Hamid; Neak Muhammad; Declan P Naughton
Journal:  BMC Chem       Date:  2019-08-14

6.  Comfort in big numbers: Does over-estimation of doping prevalence in others indicate self-involvement?

Authors:  Andrea Petróczi; Jason Mazanov; Tamás Nepusz; Susan H Backhouse; Declan P Naughton
Journal:  J Occup Med Toxicol       Date:  2008-09-05       Impact factor: 2.646

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.